Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product SolutionPRNewsWire • 04/22/24
Par Pharmaceutical Issues Voluntary Nationwide Recall of One Lot of Treprostinil Injection Due to Potential for Silicone Particulates in the Product SolutionPRNewsWire • 03/12/24
Endo Reaches Resolution with U.S. Department of Justice Regarding Legacy Marketing of Opana® ERPRNewsWire • 02/29/24
Endo Announces Publication of New XIAFLEX® (collagenase clostridium histolyticum) Survey Data in Journal of Hand Surgery Global OpenPRNewsWire • 01/24/24
Endo Announces New Data for Dupuytren's Contracture Presented at the American Association for Hand Surgery Annual MeetingPRNewsWire • 01/19/24
ENDO FILES PLAN OF REORGANIZATION TO IMPLEMENT PREVIOUSLY ANNOUNCED SALE TRANSACTIONPRNewsWire • 12/19/23
Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual MeetingPRNewsWire • 09/21/23
Endo and Premier, Inc. Collaborate to Address Pitocin® (oxytocin injection, USP) ShortagePRNewsWire • 07/17/23